Isabelle Ourliac-Garnier

Dr. Isabelle Ourliac-Garnier

orcid

Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 December 2019 in Pharmaceuticals
Verified
Journal Article
Open access
PDF file
MAMohammed Aldholmi
Mohammed Aldholmi
Pascal MarchandPascal Marchand
Pascal Marchand
Isabelle Ourliac-GarnierIsabelle Ourliac-Garnier
Isabelle Ourliac-Garnier
Patrice Le PapePatrice Le Pape
Patrice Le Pape
A GanesanA Ganesan
A Ganesan
In this review, we discuss novel natural products discovered within the last decade that are reported to have antifungal activity against pathogenic species. Nearly a hundred natural products were identified that originate from bacteria, algae, fungi, sponges, and plants. Fungi were the most prolific source of antifungal compounds discovered during the period of review. The structural diversity of these antifungal leads encompasses all the major classes of natural products including polyketides, shikimate metabolites, terpenoids, alkaloids, and peptides.

14 July 2005 in Biochemistry
Verified
Journal Article
Closed access
Isabelle Ourliac-GarnierIsabelle Ourliac-Garnier
Isabelle Ourliac-Garnier
MEMiguel-Angel Elizondo-Riojas
Miguel-Angel Elizondo-Riojas
SRSophie Redon
Sophie Redon
NFNicholas P. Farrell
Nicholas P. Farrell
SBSophie Bombard
Sophie Bombard

15 December 2009 in Genes & Development
Verified
Journal Article
Closed access
PDF file
NANausica Arnoult
Nausica Arnoult
CSCarole Saintomé
Carole Saintomé
Isabelle Ourliac-GarnierIsabelle Ourliac-Garnier
Isabelle Ourliac-Garnier
JRJean-Francois Riou
Jean-Francois Riou
ALArturo Londoño-Vallejo
Arturo Londoño-Vallejo
Mechanisms of telomere replication remain poorly defined. It has been suggested that G-rich telomeric strand replication by lagging mechanisms requires, in a stochastic way, the WRN protein. Here we show that this requirement is more systematic than previously thought. Our data are compatible with a situation in which, in the absence of WRN, DNA synthesis at replication forks is uncoupled, thus allowing replication to continue on the C strand, while single G strands accumulate. We also show that in cells in which both WRN and POT1 are limiting, both G- and C-rich telomeric strands shorten, suggesting a complete replication block. Under this particular condition, expression of a fragment spanning the two POT1-OB (oligonucleotide-binding) fold domains is able to restore C (but not G) strand replication, suggesting that binding of POT1 to the lagging strand allows DNA synthesis uncoupling in the absence of WRN. Furthermore, in vitro experiments indicate that purified POT1 has a higher affinity for the telomeric G-rich strand than purified RPA. We propose a model in which the relative enrichments of POT1 versus RPA on the telomeric lagging strand allows or does not allow uncoupling of DNA synthesis at the replication fork. Our study reveals an unanticipated role for hPOT1 during telomere replication.

3 January 2020 in Journal of Enzyme Inhibition and Medicinal Chemistry
Verified
Journal Article
Open access
FPFabrice Pagniez
Fabrice Pagniez
NLNicolas Lebouvier
Nicolas Lebouvier
YNYoung Min Na
Young Min Na
Isabelle Ourliac-GarnierIsabelle Ourliac-Garnier
Isabelle Ourliac-Garnier
CPCarine Picot
Carine Picot
Patrice Le PapePatrice Le Pape
Patrice Le Pape
(2-(2,4-Dichlorophenyl)-3-(1H-indol-1-yl)-1-(1,2,4-1H-triazol-1-yl)propan-2-ol (8 g), a new 1,2,4-triazole-indole hybrid molecule, showed a broad-spectrum activity against Candida, particularly against low fluconazole-susceptible species. Its activity was higher than fluconazole and similar to voriconazole on C. glabrata (MIC90 = 0.25, 64 and 1 µg/mL, respectively), C. krusei (MIC90 = 0.125, 64 and 0.125 µg/mL, respectively) and C. albicans (MIC90 = 0.5, 8 and 0.25 µg/mL, respectively). The action mechanisms of 8 g were also identified as inhibition of ergosterol biosynthesis and phospholipase A2-like activity. At concentration as low as 4 ng/mL, 8g inhibited ergosterol production by 82% and induced production of 14a-methyl sterols, that is comparable to the results obtained with fluconazole at higher concentration. 8 g demonstrated moderate inhibitory effect on phospholipase A2-like activity being a putative virulence factor. Due to a low MRC5 cytotoxicity, this compound presents a high therapeutic index. These results pointed out that 8 g is a new lead antifungal candidate with potent ergosterol biosynthesis inhibition.

1 March 2020 in European Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
DMDavid Montoir
David Montoir
RGRémi Guillon
Rémi Guillon
SGSophie Gazzola
Sophie Gazzola
Isabelle Ourliac-GarnierIsabelle Ourliac-Garnier
Isabelle Ourliac-Garnier
KSKossi Efouako Soklou
Kossi Efouako Soklou
CLcédric logé
cédric logé

1 January 2021 in European Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
MBMarc-Antoine Bazin
Marc-Antoine Bazin
SCSandrine Cojean
Sandrine Cojean
FPFabrice Pagniez
Fabrice Pagniez
GBGuillaume Bernadat
Guillaume Bernadat
CCChristian Cavé
Christian Cavé
Pascal MarchandPascal Marchand
Pascal Marchand